Company ProfilePremium

Huon Aquaculture Group Limited

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Huon Aquaculture Group Limited - Company showcase

Year Founded & Workforce

1986

900 Employees

Huon Aquaculture Group Limited logo

Huon Aquaculture Group Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Huon Aquaculture Group Limited Overview

Huon Aquaculture is a vertically integrated Tasmanian salmonid farmer. Its operations run from broodstock and hatcheries through land-based nurseries, marine grow-out, processing, value-added smoking and national distribution. The company was founded by the Bender family in 1986 and listed on the ASX in 2014. It built a distinctive identity around high-energy offshore farming, notably its self-designed "Fortress" pens in exposed Storm Bay, and around large-smolt strategies that shorten the time fish spend at sea. Biological shocks (a 2018 jellyfish bloom and warm summers) and COVID-19 price dislocation pushed the group into a A$128m statutory loss in FY2021. It was then sold to JBS, for which it became the first aquaculture platform globally. Under JBS ownership Huon is investing about A$130m to A$140m in recirculating aquaculture systems (RAS). In FY2026 it overtook Cooke-owned Tassal as Tasmania's largest producer by volume. Its operating environment, however, has become sharply more contested because of disease-driven mass mortalities, animal-welfare controversies and a state government moratorium on marine expansion.


What the company does. Huon breeds, grows, harvests, processes and sells Atlantic salmon (Salmo salar) and ocean trout (sea-farmed rainbow trout). Its value chain is fully integrated:

  1. Breeding and broodstock. For around two decades Huon took part in the CSIRO-led Tasmanian salmon selective breeding program. It has since moved to its own in-house breeding program to gain more autonomy over genetics (Tasmanian Country, reporting comments from breeding program manager Lewis Rands). A new A$20m RAS broodstock facility is being built at Lonnavale.

  2. Freshwater hatcheries. Historically Huon produced fry at four hatcheries (Forest Home, Lonnavale, Springfield and Bridport) and on-grew fish at freshwater sites including Meadowbank and Millybrook (Hatchery International).

  3. Land-based nursery (post-smolt). The Whale Point RAS nursery at Port Huon grows large smolts. An A$110m expansion will give capacity for more than 7 million fish and recycle 99% of water.

  4. Marine grow-out. Leases in the Huon River and D'Entrecasteaux Channel, the high-energy Storm Bay sites (a 20,000-tonne lease allocation), and Macquarie Harbour on the west coast.

  5. Harvest and primary processing. Southern operations around Hideaway Bay and Dover, and the Parramatta Creek processing facility in north-west Tasmania.

  6. Value-added processing and distribution. Smoked salmon and ocean trout, fresh portions, and a processing and distribution facility at Ingleburn, NSW (opened April 2019) serving Sydney and the eastern seaboard.

  7. By-products. A planned A$20m rendering facility to turn processing waste into fish meal and salmon oil. Whale Point sludge already goes to horticultural composting (Cherries Tasmania).

Revenue model. Revenue comes essentially 100% from product sales: whole fish, fillets, portions, and smoked or value-added products. There is no material service, subscription or licensing revenue. Sales channels historically comprised:

Domestic retail: (major supermarket chains, branded and private label)

Domestic wholesale: (fish markets, foodservice)

Export: (spot and contracted sales, mainly Asia)

COVID-19 severely disrupted the wholesale and export channels in FY2020 (company disclosure as reported by SalmonBusiness). Export share has varied widely:

  • H1 FY2018: 29% of volume (3,710 t) exported

  • H1 FY2019: 94% of harvest sold in Australia

  • At the 2021 acquisition: JBS described about 15% of production as exported

  • 2025/26: Huon's supply was characterised as roughly evenly split between Australian and international markets (Tasmanian Country)

Customer types. Australian supermarket chains, seafood wholesalers and fish markets, foodservice and restaurants, and Asian importers. Under JBS, Huon is explicitly targeting China, where it competes with Norwegian suppliers (SalmonBusiness, 2025).

Company's own description. Huon's latest public self-descriptions (website and project pages) emphasise "continuous innovation", industry-leading technology, growing fish longer on land, and being a global leader in aquaculture. The last full annual report was the FY2021 report (Huon Aquaculture Group Limited, year ended 30 June 2021). No subsequent standalone annual report has been published.

Independent characterisation. Huon is a mid-scale, high-cost-environment salmon farmer (about 35 kt HOG) operating at the biological margin of the species. Tasmanian summer water temperatures regularly exceed salmon comfort thresholds. This drives recurring amoebic gill disease (AGD), and the endemic bacterium Piscirickettsia salmonis has become a major mortality driver since 2025. The strategic response, both pre- and post-JBS, has been capital-intensive:

  • offshore high-energy sites

  • huge wellboats for freshwater bathing

  • RAS to cut marine exposure

Under JBS, Huon gives a meat-dominated protein group an aquaculture option and diversification within its Australian platform. Its economics are now opaque to outsiders, however, because they are folded into JBS Australia.

Strategy

Strategic themes (latest public statements, 2024–2026):

  1. "Grow fish longer on land." RAS investment reduces marine exposure, so fish go to sea larger and spend less time in the marine environment. Huon cites about 10 months at sea versus an industry average of about 14 months.

  2. Year-round production consistency. The Whale Point expansion is framed as enhancing year-round supply.

  3. Genetic autonomy. Huon has exited the CSIRO breeding program for an in-house breeding program, supported by the Lonnavale broodstock RAS.

  4. Circular economy and waste. A rendering plant for fish meal and salmon oil to ease pressure on Tasmania's limited composting capacity. Sludge is reused in horticulture.

  5. International market development. Leveraging JBS's network, with China a named target.

  6. Regulatory engagement. Huon publicly argues that the industry is adequately regulated and economically vital. It has described the 2025 review as driven by misinformation, while stating its investments will continue regardless.

Strategic initiatives in the last 24 months:

Cost programs and medium-term financial targets: not publicly disclosed. JBS does not provide Huon-specific guidance. The listed-era targets were 30,000 t by FY2021 (achieved: about 35.5 kt) and long-run growth of about 10% a year in line with the market.

Products & Services

Huon is a single-business company, so the portfolio is organised by product family. Detailed SKU-level lists, list prices and launch dates are not publicly disclosed. The table records what is verifiable.

Flagship operating assets, which define the product's provenance proposition:

Fortress pens: Self-developed heavy-duty, seal-resistant pens for high-energy sites (Storm Bay).

Ronja Storm: World's largest wellboat at delivery, on a 10-year contract with Sølvtrans. It has large freshwater-generating capacity for AGD bathing.

Ronja Huon: Earlier wellboat, used for smolt transfer at Port Huon.

Huon Hogan: 600-tonne feed barge at Storm Bay.

Whale Point RAS nursery: Grows large post-smolts, lifting average smolt-to-sea weight from 210 g to 300 g (2019). Huon has also targeted about 1 kg nursery fish.

Product Portfolio

Product familyDescriptionKey attributesTarget customerChannelPricing model

Fresh Tasmanian Atlantic salmon, whole HOG

Whole gutted fish

Average harvest weight 4.40 kg (FY2019) to a record 5.77 kg (H1 FY2021). Average realised price A$11.97/kg HOG (FY2021).

Wholesalers, export importers

Wholesale, export

Spot and contract per kg HOG

Fresh salmon fillets and portions

Skin-on and skinless fillets and retail portions

Processed in Tasmania and at Ingleburn NSW for east-coast freshness

Supermarkets, foodservice

Retail, foodservice

Contracted retail supply; per-kg pricing n/d

Smoked salmon (cold and hot smoked)

Value-added smoked range under the Huon brand

Premium brand positioning

Retail consumers

Retail

—

Smoked ocean trout

Sea-farmed rainbow trout, smoked

Shown in trade imagery as a flagship branded product (SeafoodSource)

Retail consumers

Retail

—

Fresh ocean trout

Rainbow trout grown in marine pens

Second species

Retail, wholesale

Retail, wholesale

—

Yellowtail kingfish (historic trials)

Trial farming including a WA (Geraldton) aquaculture licence

Trial or exploratory; current status n/d

———

Fish meal and salmon oil (planned)

Rendering of viscera, heads, frames and mortalities (up to 16,640 t a year of inputs)

Suitable for human or animal use

Feed and oil markets

B2B

—

Horticultural sludge / compost input

Whale Point RAS sludge (about 400 t a year to Cherries Tasmania)

Circular-economy by-product

Horticulture

B2B

—

Financial Narrative

Source basis: Huon ASX results releases and annual reports FY2018 to FY2021, as reported by SeafoodSource, FishFarmingExpert, SalmonBusiness and The Examiner. FY2017 figures are implied from FY2018 growth rates. No figures have been published for FY2022 to FY2026.

Income statement

Notes on the income statement:

  • FY2021 operating EBITDA was guided at A$15m to A$20m (market updates, May/June 2021).

  • FY2020 statutory NPAT is reported as A$4.9m by FishFarmingExpert but A$3.9m by SeafoodSource. A$4.9m is used here, matching the A$9.5m comparative and the 2020 annual report coverage.

  • FY2021 revenue is described as +24% on FY2020, but A$426.4m / A$339.9m = +25.4%. This may reflect a restated FY2020 comparative.

  • Gross profit, operating income (EBIT) and pre-tax income are not available from retrieved sources (n/d).

  • EPS: n/d as reported. Indicatively, the FY2021 statutory loss over about 110m shares implies roughly -116 cents per share (implied).

  • Dividends: suspended for FY2020 (H1 FY2020 announcement). None for FY2021. Earlier dividend history n/d.

Half-year detail

Further half-year detail:

  • H1 FY2018 operating profit was A$39.2m.

  • H1 FY2019 harvest is cited as 9,019 t (FishFarmingExpert) versus 9,012 t (SeafoodSource), a minor discrepancy.

  • H1 FY2020 operating NPAT was A$3.7m (SeafoodSource).

  • H1 FY2021 included a post-tax impairment of A$79.9m (A$113.9m pre-tax). Operating NPAT was -A$15.4m.

Margins (calculated from the tables above)

The FY2021 EBITDA margin uses the A$17.5m guidance midpoint and is indicative only.

Revenue CAGR: FY2018 to FY2021 is approximately 10.3% a year (A$317.9m to A$426.4m). FY2017 to FY2021 (using implied FY2017) is approximately 13.3% a year.

Unit economics

  • FY2020 average price is implied from the stated 10% fall to A$11.97 in FY2021.

  • Revenue per tonne is calculated and includes value-added uplift.

  • Half-year average weights: 5.07 kg (H1 FY2020) and a record 5.77 kg (H1 FY2021), with 4.73 kg in H2 FY2021.

  • Revenue per kg fell from A$15.11 (H1 FY2019) to A$13.37 (H1 FY2020).

  • Guided FY2020 cost of production including freight was above A$11.50/kg HOG.

Balance sheet and cash flow

The August 2020 placement (A$64m) technically settled in FY2021 (28 August 2020) but was announced with the FY2020 results. There were no buybacks in the period.

Ratios

ROE, ROA, ROIC, current ratio, debt/equity, interest coverage, asset turnover and cash conversion cycle cannot be calculated reliably without the balance sheet (n/d). Calculable indicators:

Commentary on trends, inflections and drivers

FY2017 to FY2018: growth peak. Revenue rose 23% and harvest 25%, and operating NPAT reached a record A$35.4m. This was the payoff from the early phase of the 2014 Controlled Growth Strategy and from tight domestic supply that held prices up. Even so, the second half of FY2018 was harmed by warm water and AGD. That pulled harvest forward and left FY2019 with lower biomass.

FY2019: biological shock. The moon jellyfish bloom of late 2018 caused gill necrosis. Combined with water slow to cool below 16°C, it cut harvest by 18% to 18,849 t and average weight to 4.40 kg. Operating EBITDA fell about 34–35% to A$47.3m and statutory NPAT fell 64% to A$9.5m. At the same time, rebuilding biomass absorbed working capital. Operating cash flow collapsed 75% to A$14.5m while capex was A$64.3m, so net debt rose by A$57.5m to A$138.8m. This was the critical balance-sheet inflection.

FY2020: volume recovery, price compression and COVID-19. Harvest rebounded 36% to 25,566 t. The 19 Year Class was described as the company's best-ever cohort (biggest fish, highest survival, better FCR). However:

  • Pricing fell about 11% as channel mix shifted toward lower-priced export.

  • From March 2020, COVID-19 closed wholesale and disrupted export, forcing Huon to slow harvest and hold fish in the water.

  • Operating cash flow fell to A$8.4m and net debt rose about 21%.

  • The A$64m placement at A$3.00 (versus about A$4.51 in July 2020) was dilutive and defensive.

FY2021: volume at record, value destroyed. Harvest rose about 39% (to roughly 35.5 kt) and revenue rose to A$426.4m. But the average price fell 10% to A$11.97/kg because global salmon prices were depressed and freight costs were elevated. Warm summer conditions in H2 cut average weight to 4.73 kg and raised feed costs. Management cut its expectations for future cash flows, triggering a A$113.9m pre-tax impairment. The A$128m statutory loss, thin EBITDA (A$15m to A$20m guided) and stretched leverage made a corporate transaction close to inevitable.

Structural reading. Huon's five-year record shows a classic farmed-salmon pattern: capital-heavy expansion funded by debt, then a run of adverse biological years and a price shock. Volume grew about 55% from FY2018 to FY2021 while EBITDA collapsed. The A$350m investment program improved biology (larger smolts, offshore sites, bathing capacity), but its benefits, by management's own admission, were back-end loaded into FY2022 and beyond. JBS captured those benefits after acquiring the company.

FY2022 to FY2026 (private). No financial disclosure is available. Indicators:

  • Production fell to 27,321 t HOG in FY2025, consistent with the 2025 P. salmonis mortality event.

  • Production rebounded 26.6% to 34,588 t in FY2026.

  • JBS has kept funding large capex: A$110m at Whale Point, A$20m for Lonnavale broodstock RAS, and a A$20m rendering plant (relocation pending).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Margin Analysis (%)

MetricFY2017FY2018FY2019FY2020FY2021

Revenue AUD Mn

258.5317.9282.0339.9426.4

Operating EBITDA AUD Mn (FY2017 implied; FY2020 implied from +11%)

63.071.847.352.5—

Operating NPAT AUD Mn

28.835.415.9——

Statutory NPAT AUD Mn

—26.49.54.9-128.0

Financial Analysis

MetricH1FY2018H1FY2019H1FY2020H1FY2021

Revenue AUD Mn

170.5136.3178.1220.0

Harvest tonnes

12,6939,01913,300—

Statutory NPAT AUD Mn

27.626.422.0-95.3

Operating EBITDA AUD Mn

———9.5

Margin Analysis (%) — Operating EBITDA margin pct

MetricFY2017FY2018FY2019FY2020FY2021

Operating EBITDA margin pct

24.422.616.815.44.1

Statutory net margin pct

—8.33.41.4-30.0

Operating NPAT margin pct

11.111.15.6——

Financial Analysis (FY2018–FY2021)

MetricFY2018FY2019FY2020FY2021

Average harvest weight kg

4.784.40——

Average realised price A$ per kg HOG

——13.3011.97

Revenue per harvest tonne AUD K

13.8414.9613.2912.00

Margin Analysis (%) (FY2018–FY2021)

MetricFY2018FY2019FY2020FY2021

Operating cash flow AUD Mn

57.914.58.4—

Capital expenditure AUD Mn

—64.3——

Net debt AUD Mn (FY2018 implied; FY2020 implied from +21%)

81.3138.8168.0—

Equity raised AUD Mn

0064.00

Financial Analysis (FY2018–FY2020)

RatioFY2018FY2019FY2020

Net debt / operating EBITDA x

1.12.93.2

Operating cash conversion (OCF / operating EBITDA) pct

80.630.716.0

Revenue by Region (%)

MetricH1FY2018H1FY2019FY2021FY2026

Export share of volume pct

2961550

Domestic share of volume pct

71948550

Capital Markets

MetricJul2020Aug2020Aug2021Nov2021

HUO share price reference A$

4.513.003.853.85

Valuation Snapshot

MetricValue

Equity value AUD Mn

425

EV / FY2021 revenue x (equity value only, excl. net debt)

1.0

Equity value / FY2020 operating EBITDA x

8.1

Analyst Conclusions

Management guidance: none is publicly issued. Qualitative signals from CEO von der Heyde and JBS Australia (2025–2026):

  • Investments continue regardless of the moratorium.

  • The moratorium is expected to last about a year.

  • Growth is targeted in China.

  • Whale Point is to be fully operational in 2027.

Consensus expectations: not applicable (no analyst coverage of Huon).

Bull case:

  1. Volume leadership compounding with RAS. Huon reached 34,588 t in FY2026 (+26.6%) and became Tasmania's No. 1. With Whale Point's expanded RAS adding larger fish and shorter sea time from 2027, Huon could lift output and survival without new marine leases, which neutralises the moratorium.

  2. JBS capital and distribution. A parent able to fund about A$150m of capex through a crisis, plus a global sales network, addresses both historic constraints that led to the 2021 sale: balance sheet and market access. The shift of supply toward about 50% export suggests the network is already working.

  3. Oligopoly pricing. With Huon and Tassal holding about 92% of Tasmanian supply and both under deep-pocketed owners (JBS and Cooke), rational domestic pricing and premium positioning are durable.

Bear case:

  1. Endemic disease plus warming. P. salmonis drove more than 20,133 t of industry mortalities in 2025 and more than 9,000 t in Q1 2026. Huon's southern Channel sites were the epicentre in 2025. Recurrent events destroy biomass value, as FY2019 and FY2025 showed.

  2. Regulatory tightening. The 2026 independent study could make the moratorium permanent, impose stocking caps, stricter antibiotic and welfare rules, or force lease relocations. Huon's antibiotic episodes (February 2025, February 2026) and the loss of RSPCA certification weaken its negotiating position.

  3. Structurally high costs versus global price-setters. In FY2021 a 10% price drop plus freight costs turned record volume into a A$128m loss. Tasmania's cost base and biology make Huon a price-taker in export markets, where Norway and Chile set pricing.

Key catalysts and monitorables (next 12 months):

  • Final findings of the Tasmanian Salmon Industry Independent Study (2026) and any decision on lifting the moratorium.

  • Summer 2026/27 mortality data (EPA weekly reporting).

  • Whale Point RAS commissioning progress toward 2027.

  • Confirmation that the Lonnavale broodstock RAS is operational.

  • Site selection and approval for the relocated rendering plant.

  • Any regulatory outcome from the Meadowbank antibiotic matter.

  • Re-certification efforts (RSPCA or alternatives).

  • JBS group disclosures of Australian business-unit performance as a proxy for Huon.

  • FY2027 state production data, published around September 2027.

Analyst verdict. Huon Aquaculture is a case study of how a strategically sound but capital-hungry aquaculture business can fail as a listed small-cap and then be rescued, and potentially vindicated, under a deep-pocketed strategic owner. Between FY2018 and FY2021 the Bender-led company did much of the right engineering: offshore Storm Bay leases, Fortress pens, the world's largest wellboat and a pioneering RAS nursery. Biology, a jellyfish bloom and COVID-era price collapse arrived before the payback. Net debt more than doubled, operating cash flow dried up, and a A$128m loss left the board little choice but to sell at A$3.85 per share.

Five years on, the operating evidence is mixed but increasingly favourable on volume. Huon is now Tasmania's largest producer and recovered strongly in FY2026 after the 2025 mortality catastrophe. JBS has kept funding a land-based strategy that directly targets Huon's core vulnerability, time at sea in warming water.

The risks, however, have shifted from financial to social and regulatory. The 2025 events stripped Huon of its RSPCA credential, exposed weaknesses in incident communication, and triggered a state moratorium and an independent study whose findings will set the industry's licence to grow for a decade. Endemic P. salmonis is not a one-off; Q1 2026 mortalities show the pressure persists.

For external stakeholders the defining weakness is opacity. Without standalone financials it is impossible to judge whether JBS is earning a return on the roughly A$425m purchase price plus subsequent capex.

Our assessment: operationally improving, strategically well-capitalised, but carrying elevated regulatory and biological tail risk. The investment thesis for JBS rests on RAS execution through 2027 and a workable outcome from the 2026 study. A negative regulatory outcome combined with another severe summer would be the scenario most likely to force a strategic rethink of JBS's aquaculture ambitions.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior roles

Charles von der Heyde

Chief Executive Officer, Huon Aquaculture

From May 2025

President, Pilgrim's Mexico. Earlier SVP Commodity Risk Management, Feed Ingredient Purchasing and Export Sales at Pilgrim's (from 2010). More than 9 years at Bunge.

Hannah Gray

General Manager, Corporate Governance

——

Lewis Rands

Breeding Program Manager

——

Brent Eastwood

CEO, JBS Australia (parent oversight)

—

Led the JBS side of the 2021 acquisition

Gilberto Tomazoni

Global CEO, JBS

—

Announced Huon as JBS's strategic entry into aquaculture

Peter Bender

Co-founder, CEO and Managing Director

1986 to 2021

Co-controlled about 53% with Frances Bender before the sale

Frances Bender

Co-founder, Executive Director

1986 to 2021

—

Neil Kearney

Chairman

Through November 2021

Led the strategic review and JBS process

Phil Wiese

Deputy CEO

Listed era

—

David Mitchell

GM Freshwater

Listed era

—

Henrique (Henry) Batista

CEO

About late 2021/2022 to February 2025

Member of the JBS founding family. Now brands and snacking director, Pilgrim's Europe.

Major Shareholders

HolderStakePeriod

JBS (via JBS Australia)

100%

Since 17 Nov 2021

Peter and Frances Bender

~53%

Pre-acquisition

Tattarang (Andrew Forrest)

18.5%

Aug–Nov 2021

AustralianSuper

12.6%

2021 (per AGM questions, Mayne Report)

Competitive Landscape

Key Competitors

CompetitorOwner / listingRelevanceScale indicator

Tassal

Cooke Inc. (private, Canada); acquired from the ASX in 2022

Main domestic rival in retail and export

33,388 t HOG FY2026 (Tas NRE)

Petuna

Private (Tasmania)

Third Tasmanian producer; ocean trout and salmon

6,272 t HOG FY2026

Mowi

Oslo Børs: MOWI

Global leader; Norwegian supply competes in China and Asia

—

SalMar

Oslo Børs: SALM

Norwegian major; offshore farming peer

n/d in this session

Lerøy Seafood

Oslo Børs: LSG

Norwegian integrated major

n/d in this session

Cermaq

Mitsubishi Corporation

Norway / Chile / Canada supplier into Asia

n/d in this session

Bakkafrost

Oslo Børs: BAKKA

Faroese/Scottish premium salmon

n/d in this session

AquaChile (Agrosuper)

Private (Chile)

Chilean supplier into Asia

n/d in this session

New Zealand King Salmon

NZX/ASX: NZK

King salmon competing in Australian premium foodservice

n/d in this session

Clean Seas Seafood

ASX: CSS

Yellowtail kingfish, a substitute premium finfish

n/d in this session

Scottish Sea Farms

Private (Lerøy/SalMar JV)

Listed by CB Insights as a comparable

n/d in this session

Peer Comparison FY2026

MetricHuonTassalPetuna

FY2026 HOG production t

34,58833,3886,272

FY2025 HOG production t

27,32133,5237,139

YoY growth pct

26.6-0.4-12.1

Share of Tasmanian output FY2026 pct

46.645.08.4

Recent Developments

The register includes directly relevant industry and regulatory events.

Company Snapshot

900

Employees

1986

Founded

SWOT Analysis

Strengths

  • Volume leadership: Tasmania's largest producer in FY2026 at 34,588 t HOG (Tas NRE).
  • Fast recovery: production +26.6% in FY2026 after the 2025 mortality event.
  • Land-based capability: Whale Point RAS (more than 7m fish capacity after expansion, 99% water recycling). Fish spend about 10 months at sea versus the industry's 14.
  • High-energy offshore leases: a 20,000 t Storm Bay allocation, plus Fortress pen and feed-barge infrastructure.
  • Bathing and biosecurity assets: a 10-year contract for the Ronja Storm, the world's largest wellboat at delivery.
  • Deep-pocketed parent: JBS funded about A$150m+ of announced capex since 2023 (A$110m plus A$20m plus a A$20m rendering plant).
  • Vertical integration through east-coast distribution (Ingleburn, opened 2019).

Weaknesses

  • Biological volatility: harvest fell 18% in FY2019 and production fell to 27,321 t in FY2025.
  • Historic earnings fragility: statutory loss of A$128m in FY2021 and an impairment of A$113.9m pre-tax.
  • Historic leverage: net debt rose to A$138.8m in FY2019 and roughly a further 21% in FY2020.
  • Loss of RSPCA certification in March 2025, removing a retail welfare credential.
  • Communication shortcomings during incidents, acknowledged by the CEO in 2025 and criticised in the government debrief, which referred to an insufficient response.
  • Opacity: no standalone financial disclosure since FY2021, which limits stakeholder trust.
  • Leadership churn: three CEOs since 2021 (Bender, Batista, von der Heyde).

Opportunities

  • Export growth: supply is already about half international, and China has been named as a target.
  • Higher volume from bigger smolts as Whale Point comes fully online (2027).
  • By-product revenue (fish meal and salmon oil) from rendering, processing up to 16,640 t of inputs a year.
  • Genetics: in-house breeding for disease and temperature resilience.
  • Consolidated domestic market (two-player oligopoly), which supports pricing.
  • Vaccine and husbandry advances against P. salmonis (10 million fish vaccinated, 2025).
  • A clear regulatory framework after the study could unlock leases if the outcome is favourable.

Threats

  • Endemic P. salmonis: more than 20,133 t of industry mortalities in 2025 and more than 9,000 t in Q1 2026.
  • The marine expansion moratorium (since August 2025) and possible tighter caps from the 2026 study.
  • Antibiotic-use controversy: OTC in February 2025 and the Meadowbank episode in February 2026.
  • Wildlife deaths: four dolphins in H1 2025.
  • Climate warming in the Channel and Storm Bay.
  • Global price competition from Norway and Chile, the cause of the FY2021 collapse to A$11.97/kg.
  • NGO and political campaigns affecting retail customers.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Feb 2025 (context)Mortality event begins in the lower D'Entrecasteaux Channel. Fish-oil globules wash up on beaches including Verona Sands and Bruny Island.Largest-ever Tasmanian mortality; reputational crisis
13–26 Feb 2025 (context)Huon doses oxytetracycline via medicated feedAntibiotic scrutiny
Feb 2025 (context)CEO Henry Batista departsLeadership gap during the crisis
Mar 2025 (context)RSPCA suspends and then withdraws certification after Bob Brown Foundation drone footage of fish handlingLoss of the welfare credential
Mar–Jun 2025Four short-beaked common dolphins die in Huon pen infrastructure (1 in the Channel in March, 2 in Storm Bay in May, 1 in June)Wildlife-interaction scrutiny
April 2025EPA independent monitoring finds no further antibiotic residues in water, sand or wild fishPartial reassurance
Feb–early May 2025EPA declares the mortality event over. Data released in May 2025 put mortalities at about 10 million kg over two months (Greens citing EPA).Scale confirmed
14 May 2025Charles von der Heyde appointed CEONew JBS-sourced leadership
Aug 2025Premier Rockliff announces an independent salmon industry study and a pause on marine expansionGrowth ceiling on marine leases
Aug–Sep 2025Salmon Tasmania condemns the pause. Huon's CEO describes the review as gossip-driven and says investments will continue.Industry–government friction
2025Industry-wide vaccination of 10 million fish against *P. salmonis*Disease mitigation
2025JBS Australia CEO Eastwood states he is not concerned about the reviewParent-level signalling
Oct 2025NRE/EPA publish the "Reflections and Learnings" debrief naming Huon Aquaculture Company Pty Ltd as a directly affected operatorRegulatory record
27–30 Oct 2025Study terms of reference announced and finalised. Study to run in two phases through 2026.Regulatory roadmap
Late 2025Lonnavale broodstock RAS construction scheduled to startCapex execution
Calendar 2025Total Tasmanian salmon mortalities exceed 20,133 t, including about 2,500 t in Q4 (EPA via Huon News). December daily mortalities exceed 40 t per day (EPA via AOL).Chronic biological stress
Jan 2026Tassal (competitor) begins florfenicol medicated feed near Bruny IslandIndustry-wide disease pressure
Feb 2026Scrutiny of OTC use at the Meadowbank freshwater hatchery without notifying downstream water usersFreshwater compliance risk
Early 2026Lonnavale broodstock RAS targeted to be fully operational–
17 Apr 2026EPA data: more than 9,000 t of farmed salmon died in Tasmania in Q1 2026Mortality remains elevated
2026EPA introduces weekly mortality reporting with suspected causesTighter regulation
2026Independent study in progress (phases 1–2)Outcome pending
10 Sep 2026State data: Huon becomes Tasmania's largest salmon producer in FY2026 (34,588 t HOG, +26.6%)Volume leadership
FY2026Tasmanian industry output rises 9.2% to 74,249 t HOGSector recovery
2025/26Huon confirms its exit from the CSIRO breeding program for in-house geneticsStrategic autonomy
2025/26Huon's general manager of corporate governance criticises the "politicisation" of aquacultureStakeholder stance
2025–2027Whale Point A$110m RAS under constructionCapacity and biosecurity
OngoingRendering plant relocation searchWaste-management capability pending

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

1 chart
Revenue by Region (%): Export share of volume pct rose from 29% in 2018 to 50% in FY2026.
Huon Aquaculture Group Limited — Revenue by Region (%)
Series (%)20182019FY2021FY2026
Export share of volume pct2961550
Domestic share of volume pct71948550

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. SalmonBusiness, "Huon: overtakes Tassal as Tasmanian salmon output jumps 9%" (10 Sep 2026) (salmonbusiness.com)
  2. SalmonBusiness, "Huon Aquaculture questions need for government salmon review" (2025) (salmonbusiness.com)
  3. SalmonBusiness, "Von der Heyde named CEO of Huon as JBS reshuffles leadership" (15 May 2025) (salmonbusiness.com)
  4. IntraFish, "Australian salmon farmer appoints new CEO" (14 May 2025) (intrafish.com)
  5. WeAreAquaculture, "Huon Aquaculture has a new CEO" (weareaquaculture.com)
  6. WeAreAquaculture, "Tasmanian salmon producer Huon expands land-based facilities" (2024) (weareaquaculture.com)
  7. Global AgInvesting, "JBS-Owned Huon Aquaculture Earmarks A$110 M for Land-Based Salmon Production" (globalaginvesting.com)
  8. Global AgInvesting, "Huon Aquaculture Expands Salmon Production on Tasmania's North West Coast" (globalaginvesting.com)
  9. FishFarmingExpert, "Huon posts A$128m loss" (FY2021) (fishfarmingexpert.com)
  10. FishFarmingExpert, "Huon launches strategic review after corporate offers" (Feb 2021) (fishfarmingexpert.com)
  11. FishFarmingExpert, "Huon opens its books to potential buyers" (Jun 2021) (fishfarmingexpert.com)
  12. FishFarmingExpert, "Huon seeks to raise A$68m as profit falls and debt rises" (FY2020) (fishfarmingexpert.com)
  13. FishFarmingExpert, "Full benefit of Huon investment 'is still to come'" (fishfarmingexpert.com)
  14. FishFarmingExpert, "Jellyfish and warm water blamed as Huon profits plunge by 64%" (FY2019) (fishfarmingexpert.com)
  15. FishFarmingExpert, "Huon: We'll go from 19,000 tonnes to 30,000t by 2021" (fishfarmingexpert.com)
  16. FishFarmingExpert, "Huon profits stung by jellyfish" (H1 FY2019) (fishfarmingexpert.com)
  17. FishFarmingExpert, "Huon reports big jumps in volume and revenue" (H1 FY2018) (fishfarmingexpert.com)
  18. FishFarmingExpert, "Harvest grows but profit falls for Huon" (H1 FY2020) (fishfarmingexpert.com)
  19. FishFarmingExpert, "Huon to build £10m rendering plant" (fishfarmingexpert.com)
  20. FishFarmingExpert, "Huon investigating dolphin deaths at salmon farms" (2025) (fishfarmingexpert.com)
  21. FishFarmingExpert, "Brazilian meat giant linked to Huon takeover" (fishfarmingexpert.com)
  22. FishFarmingExpert Tasmania tag archive (fishfarmingexpert.com)
  23. SeafoodSource, "Australian salmon farmer posts record profit despite challenging summer" (FY2018) (seafoodsource.com)
  24. SeafoodSource, "COVID-19 impacts Huon's finances as it announces USD 47 million equity raise" (FY2020) (seafoodsource.com)
  25. SeafoodSource, "Huon Aquaculture shareholders approve JBS takeover" (seafoodsource.com)
  26. SeafoodSource, "Suitors lining up for troubled Huon Aquaculture, including JBS" (seafoodsource.com)
  27. SeafoodSource, "Tasmanian salmon-farming industry rebukes government pause on sector expansion" (seafoodsource.com)
  28. SalmonBusiness, "After bruising COVID hit half-year report, Huon initiates strategic review" (26 Feb 2021) (salmonbusiness.com)
  29. SalmonBusiness, "Fall in harvest volumes, higher operating costs and jelly fish dampen Huon's earnings" (salmonbusiness.com)
  30. The Examiner, "Bedevilled by jellyfish, Huon Aquaculture takes a dive" (examiner.com.au)
  31. The Examiner, "Huon Aquaculture targets growth after difficult year" (examiner.com.au)
  32. Food & Drink Business, "JBS acquires 100% of Huon Aquaculture" (foodanddrinkbusiness.com.au)
  33. Food & Drink Business, "Andrew Forrest doubles stake in Huon, blocks JBS" (foodanddrinkbusiness.com.au)
  34. Just Food (scheme vote; FIRB approval): and: just-food.com · just-food.com
  35. Mayne Report, 2021 Huon AGM questions (maynereport.com)
  36. Business News WA, Huon Aquaculture Group news page (businessnews.com.au)
  37. BP Money / Folhapress (court approval; completion date) (bpmoney.com.br)
  38. O Presente Rural (JBS acquisition announcement) (opresenterural.com.br)
  39. Safra – O Especialista (deal terms) (oespecialista.safra.com.br)
  40. JBS Foods Group, "Huon Aquaculture To Invest $20 Million In New Rendering Facility" (jbsfoodsgroup.com)
  41. Huon Aquaculture, Lonnavale Broodstock RAS Facility project page (huonaqua.com.au)
  42. EPA Tasmania, Maiden Meadows Rendering Facility proposal (epa.tas.gov.au)
  43. EPA Tasmania, Lonnavale Broodstock RAS proposal (epa.tas.gov.au)
  44. EPA Tasmania, Salmon Mortality Event lower D'Entrecasteaux Channel 2025 (epa.tas.gov.au)
  45. EPA Tasmania, Salmon Mortality Event 2025 page (epa.tas.gov.au)
  46. NRE Tasmania / EPA, "Reflections and Learnings: 2025 Salmon Mortality Event" (Oct 2025) (epa.tas.gov.au)
  47. Tasmanian DPAC, Salmon Industry Study (dpac.tas.gov.au)
  48. CityNews, "Animal welfare probe amid mass salmon farm deaths" (2025) (citynews.com.au)
  49. Huon News, "Dead salmon: 9,000 tonnes in 12 weeks" (2026) (huonnews.com)
  50. AOL, "Over 4 Million Salmon Died Prematurely..." (2026) (aol.com)
  51. Tasmanian Country, "'We've got nothing to hide' insists Huon Aquaculture" (tasmaniancountry.com)
  52. Tasmanian Greens parliamentary statements (2025) (tasgreensmps.org)
  53. CB Insights, Huon Aqua company profile (cbinsights.com)
  54. Hatchery International, "Huon's Forest Home Hatchery" (hatcheryinternational.com)
  55. Parliament of Tasmania, Fin Fish Farming Inquiry submission (Lonnavale) (parliament.tas.gov.au)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.